{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T02:29:38Z","timestamp":1792290578292,"version":"4.4.0"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2007,8,21]],"date-time":"2007-08-21T00:00:00Z","timestamp":1187654400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Dig Dis Sci"],"published-print":{"date-parts":[[2008,3]]},"DOI":"10.1007\/s10620-007-9900-7","type":"journal-article","created":{"date-parts":[[2007,8,20]],"date-time":"2007-08-20T16:48:49Z","timestamp":1187628529000},"page":"767-776","source":"Crossref","is-referenced-by-count":55,"title":["Methionine Deficiency and Hepatic Injury in a Dietary Steatohepatitis Model"],"prefix":"10.1007","volume":"53","author":[{"given":"Helieh S.","family":"Oz","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Theresa S.","family":"Chen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Manuela","family":"Neuman","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2007,8,21]]},"reference":[{"key":"9900_CR1","unstructured":"Lee RG, Keeffe EB (1999) Non-alcoholic fatty liver: causes and complications. In: J Bircher, Benhamou JP, McIntyre M et al (eds) Oxford, textbook of clinical hepatology, 2nd edn. Oxford University Press, Oxford, UK, pp 1251\u20131257"},{"key":"9900_CR2","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1016\/S0025-6196(11)64621-1","volume":"75","author":"KS Kumar","year":"2000","unstructured":"Kumar KS, Malet PF (2000) Nonalcoholic steatohepatitis. Mayo Clin Proc 75:733\u2013739","journal-title":"Mayo Clin Proc"},{"key":"9900_CR3","doi-asserted-by":"crossref","first-page":"1221","DOI":"10.1056\/NEJMra011775","volume":"346","author":"P Angulo","year":"2002","unstructured":"Angulo P (2002) Nonalcoholic fatty liver disease. N Engl J Med 346:1221\u20131231","journal-title":"N Engl J Med"},{"key":"9900_CR4","doi-asserted-by":"crossref","first-page":"3","DOI":"10.1053\/jhep.2000.8978","volume":"32","author":"DG Fong","year":"2000","unstructured":"Fong DG, Nehra V, Lindor KD, Buchman AL (2000) Metabolic and nutritional considerations in non-alcoholic fatty liver. Hepatology 32:3\u201310","journal-title":"Hepatology"},{"key":"9900_CR5","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.mito.2005.10.004","volume":"6","author":"K Begriche","year":"2006","unstructured":"Begriche K (2006) Mitochondrial dysfunction in NASH: causes, consequences and possible means to prevent it. Mitochondrion 6:1\u201328","journal-title":"Mitochondrion"},{"key":"9900_CR6","doi-asserted-by":"crossref","first-page":"S99","DOI":"10.1002\/hep.20973","volume":"43","author":"GC Farrell","year":"2006","unstructured":"Farrell GC (2006) Nonalcoholic fatty liver disease: from steatosis to cirrhosis. Hepatology 43:S99\u2013S112","journal-title":"Hepatology"},{"key":"9900_CR7","doi-asserted-by":"crossref","first-page":"1413","DOI":"10.1016\/S0016-5085(99)70506-8","volume":"116","author":"CA Matteoni","year":"1999","unstructured":"Matteoni CA, Younossi Z, Gramlich T, Boparai N, Liu YC, McCullough AJ (1999) Nonalcoholic fatty liver disease: a spectrum of clinical and pathological severity. Gastroenterology 116:1413\u20131419","journal-title":"Gastroenterology"},{"key":"9900_CR8","doi-asserted-by":"crossref","first-page":"74","DOI":"10.1002\/hep.1840110114","volume":"11","author":"E Powell","year":"1990","unstructured":"Powell E, Cooksley WG, Hanson R et\u00a0al (1990) The natural history of nonalcoholic steatohepatitis: a followup study of forty-two patients for up to 21\u00a0years. Hepatology 11:74\u201380","journal-title":"Hepatology"},{"key":"9900_CR9","doi-asserted-by":"crossref","first-page":"664","DOI":"10.1111\/j.1572-0241.2006.00478.x","volume":"101","author":"A Maheshwari","year":"2006","unstructured":"Maheshwari A (2006) Cryptogenic cirrhosis and NAFLD: are they related? Am J Gastroenterol 101:664\u2013668","journal-title":"Am J Gastroenterol"},{"key":"9900_CR10","doi-asserted-by":"crossref","first-page":"928","DOI":"10.1016\/j.jhep.2005.03.004","volume":"42","author":"D Pessayre","year":"2005","unstructured":"Pessayre D, Fromenty B (2005) NASH: a mitochondrial disease. J Hepatology 42:928\u2013940","journal-title":"J Hepatology"},{"key":"9900_CR11","doi-asserted-by":"crossref","first-page":"595","DOI":"10.1016\/j.cld.2004.04.009","volume":"8","author":"S Caldwell","year":"2004","unstructured":"Caldwell S, Chang Y, Nakamoto R, Krugner-Higby L (2004) Mitochondria in nonalcoholic fatty liver disease. Clin Liver Dis 8:595\u2013617","journal-title":"Clin Liver Dis"},{"key":"9900_CR12","doi-asserted-by":"crossref","first-page":"147","DOI":"10.1172\/JCI200422422","volume":"114","author":"JD Browning","year":"2004","unstructured":"Browning JD, Horton J (2004) Molecular mediators of hepatic steatosis and liver injury. J Clin Invest, 114:147\u2013152","journal-title":"J Clin Invest"},{"key":"9900_CR13","unstructured":"Pessayre D, Feldman G, Haouzi D, Fau A, Moreau A, Neuman MG (1999) Hepatocyte apoptosis triggered by natural substances (cytokines, other endogenous molecules and foreign toxins). In: Cameron RG, Fauer G (eds) Handbook of experimental pharmacology: apoptosis modulation by drugs. vol 142, Chapter 3. Springer Verlag Publishers, Heidelberg, 69\u2013109"},{"key":"9900_CR14","doi-asserted-by":"crossref","first-page":"1732","DOI":"10.1007\/s00125-006-0295-3","volume":"49","author":"M Weikert","year":"2006","unstructured":"Weikert M, Pfeiffer A (2006) Signalling mechanisms linking hepatic glucose and lipid metabolism. Diabeteologia 49:1732\u20131741","journal-title":"Diabeteologia"},{"key":"9900_CR15","doi-asserted-by":"crossref","first-page":"G852","DOI":"10.1152\/ajpgi.00521.2005","volume":"290","author":"J Reddy","year":"2006","unstructured":"Reddy J, Sambasiva Rao M (2006) Lipid metabolism and liver inflammation. Fatty liver disease and fatty acid oxidation. Am J Physiol Gastrointest Liver Physiol 290:G852\u2013G858","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"9900_CR16","unstructured":"Neuman MG, Valentino K (2003) Caspases, S-Adenosyl methionine, and anti-tumor necrosis factor alpha signaling for protection in ethanol induced apoptosis in normal human hepatocyte. J Hepatol 38(suppl 2, abs. 686):197"},{"key":"9900_CR17","doi-asserted-by":"crossref","first-page":"1202","DOI":"10.1053\/jhep.2003.50193","volume":"37","author":"BA Neuschwander-Tetri","year":"2003","unstructured":"Neuschwander-Tetri BA, Caldwell SH (2003) Nonalcoholic steatohepatitis: summary of an AASLD single topic conference. Hepatology 37:1202\u20131219","journal-title":"Hepatology"},{"key":"9900_CR18","doi-asserted-by":"crossref","first-page":"554","DOI":"10.1016\/S0002-9343(03)00449-2","volume":"115","author":"R Wang","year":"2003","unstructured":"Wang R, Koretz R, Yee H (2003) Is weight reduction an effective therapy for nonalcoholic fatty liver? A systematic review. Am J Med 115:554\u2013559","journal-title":"Am J Med"},{"key":"9900_CR19","doi-asserted-by":"crossref","first-page":"300","DOI":"10.1006\/bbrc.1999.0202","volume":"255","author":"A Enriquez","year":"1999","unstructured":"Enriquez A, Leclercq I, Farrell GC, Robertson G (1999) Altered expression of hepatic CYP2E1 and CYP4A in obese, diabetic ob\/ob mice, and fa\/fa Zucker rats. Biochem Biophys Res Commun 255:300\u2013306","journal-title":"Biochem Biophys Res Commun"},{"key":"9900_CR20","doi-asserted-by":"crossref","first-page":"128","DOI":"10.1002\/hep.510270121","volume":"27","author":"MD Weltman","year":"1998","unstructured":"Weltman MD, Farrell GC, Hall P, lngelman-Sundberg M, Liddle C (1998) Hepatic cytochrome P4502E1 is increased in patients with nonalcoholic steatohepatitis. Hepatology 27:128\u2013133","journal-title":"Hepatology"},{"key":"9900_CR21","doi-asserted-by":"crossref","first-page":"428","DOI":"10.1053\/jhep.2003.50342","volume":"38","author":"MG Emery","year":"2003","unstructured":"Emery MG, Fisher JM, Chien JY, Kharasch ED, Dellinger EP, Kowdley KV, Thummel KE (2003) CYP2E1 activity before and after weight loss in morbidly obese subjects with nonalcoholic fatty liver disease. Hepatology 38:428\u2013435","journal-title":"Hepatology"},{"key":"9900_CR22","first-page":"275","volume":"39","author":"JL Raucy","year":"1991","unstructured":"Raucy JL, Lasker JM, Kramer JC, Salazar DE, Lieber CS, Corcoran GB (1991) Induction of P45OIIE1 in the obese rat. Mol Pharmacol 39:275\u2013280","journal-title":"Mol Pharmacol"},{"key":"9900_CR23","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1016\/0926-6917(95)90059-4","volume":"293","author":"A Irizar","year":"1995","unstructured":"Irizar A, Barnett CR, Flatt PR, Ioannides C (1995) Defective expression of cytochrome P450 proteins in the liver of the genetically obese Zucker rats. Eur J Pharmacol 293:385\u2013393","journal-title":"Eur J Pharmacol"},{"key":"9900_CR24","doi-asserted-by":"crossref","first-page":"1645","DOI":"10.1016\/S0016-5085(96)70028-8","volume":"111","author":"MD Weltman","year":"1996","unstructured":"Weltman MD, Farrell GC, Liddle C (1996) Increased hepatocyte CYP2E1 expression in a rat nutritional model of hepatic steatosis with inflammation. Gastroenterology 111:1645\u20131653","journal-title":"Gastroenterology"},{"key":"9900_CR25","doi-asserted-by":"crossref","first-page":"502","DOI":"10.1093\/ajcn\/79.3.502","volume":"79","author":"CS Lieber","year":"2004","unstructured":"Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM (2004) Model of nonalcoholic steatohepatitis. Am J Clin Nutr 79:502\u2013509","journal-title":"Am J Clin Nutr"},{"key":"9900_CR26","doi-asserted-by":"crossref","first-page":"699","DOI":"10.1016\/j.bbrc.2004.01.116","volume":"315","author":"CS Lieber","year":"2004","unstructured":"Lieber CS, Leo MA, Mak KM, Xu Y, Cao Q, Ren C, Ponomarenko A, DeCarli LM (2004) Acarbose attenuates experimental non-alcoholic steatohepatitis. Biochem Biophys Res Commun 315:699\u2013703","journal-title":"Biochem Biophys Res Commun"},{"key":"9900_CR27","first-page":"91","volume-title":"Fatty liver disease; NASH and related disorders","author":"GC Farrell","year":"2005","unstructured":"Farrell GC (2005) Animal models of steatohepatitis. In: Farrell GC, George J, Hall P, McCullough AJ (eds) Fatty liver disease; NASH and related disorders. Blackwell Publishing, Malden, MA, USA, pp 91"},{"key":"9900_CR28","doi-asserted-by":"crossref","first-page":"56","DOI":"10.1016\/S0168-8278(02)00073-9","volume":"37","author":"S Seki","year":"2002","unstructured":"Seki S, Kitada T, Sakaguchi H, Nakatani K, Wakasa K (2002) In\u00a0situ detection of lipid peroxidation and oxidative DNA damage in non-alcoholic fatty liver disease. J Hepatol 37:56\u201362","journal-title":"J Hepatol"},{"key":"9900_CR29","doi-asserted-by":"crossref","first-page":"716","DOI":"10.1016\/S0168-8278(00)80301-3","volume":"33","author":"C Garcia-Monzon","year":"2000","unstructured":"Garcia-Monzon C, Martin-Perez E, Lo Iacono O, Fernandez-Bermejo M, Majano PL et\u00a0al (2000) Characterization of pathogenic and prognostic factors of nonalcoholic steatohepatitis associated with obesity. J Hepatol 33:716\u2013724","journal-title":"J Hepatol"},{"key":"9900_CR30","doi-asserted-by":"crossref","first-page":"1131","DOI":"10.1002\/hep.510290428","volume":"29","author":"A Rashid","year":"1999","unstructured":"Rashid A, Wu T-C, Huang CC, Chen CH, Lin HZ et\u00a0al (1999) Mitochondrial proteins that regulate apoptosis and necrosis are induced in mouse fatty liver. Hepatology 29:1131\u20131138","journal-title":"Hepatology"},{"key":"9900_CR31","doi-asserted-by":"crossref","first-page":"437","DOI":"10.1016\/S0016-5085(03)00907-7","volume":"125","author":"AE Feldstein","year":"2003","unstructured":"Feldstein AE, Canby A, Angulo P, Taniai M, Burgart LJ, Lindor KD, Gores GJ (2003) Hepatocyte apoptosis and FAS expression are prominent features of human nonalcoholic steatohepatitis. Gastroenterology 125:437\u2013443","journal-title":"Gastroenterology"},{"key":"9900_CR32","doi-asserted-by":"crossref","first-page":"674","DOI":"10.1002\/hep.510310318","volume":"31","author":"G Feldman","year":"2000","unstructured":"Feldman G, Haouzi D, Moreau A, Durang-Schneider A-M, Bringuier A, Berson A, Mansouri A, Fau D, Pessayre D (2000) Opening of the mitochondrial permeability transition pore causes matrix expansion and outer membrane rupture in FAS-mediated hepatic apoptosis in mice. Hepatology 31:674\u2013683","journal-title":"Hepatology"},{"key":"9900_CR33","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/S0047-6374(00)00214-1","volume":"120","author":"TS Chen","year":"2000","unstructured":"Chen TS, Richie JP, Nagasawa HT, Lang CA (2000) Glutathione monoethyl ester protects against glutathione deficiencies due to aging and acetaminophen in mice. Mech Ageing Dev 120:127\u2013139","journal-title":"Mech Ageing Dev"},{"key":"9900_CR34","doi-asserted-by":"crossref","first-page":"537","DOI":"10.1177\/147323000303100610","volume":"31","author":"J Feher","year":"2003","unstructured":"Feher J, Lengyel G (2003) A new approach to drug therapy in non-alcoholic steatohepatitis (NASH). J Int Med Res 31:537\u2013551","journal-title":"J Int Med Res"},{"key":"9900_CR35","first-page":"G125","volume":"275","author":"RK Chawla","year":"1998","unstructured":"Chawla RK, Watson WH, Eastin CE, Lee EY, Schmidt J, McClain CJ (1998) S-adenosylmethionine deficiency and TNF-alpha in lipopolysaccharide-induced hepatic injury. Am J Physiol 275:G125\u2013G129","journal-title":"Am J Physiol"},{"key":"9900_CR36","doi-asserted-by":"crossref","first-page":"987","DOI":"10.1042\/bj20021523","volume":"J370","author":"x Zhu","year":"2003","unstructured":"Zhu x, Song J, Mar M, Edwards LJ, Zeisel SH (2003) Phosphatidylethanolamine N-methyltrasferase (PEMT) knock mice have hepatic steatosis and abnormal hepatic choline metabolite concentrations despite ingesting a recommended dietary intake of choline. Biochemistry J370:987\u2013993","journal-title":"Biochemistry"},{"key":"9900_CR37","first-page":"133","volume":"10","author":"DH Baker","year":"1986","unstructured":"Baker DH (1986) Utilization of isomers and analogs of amino acids and other sulfur- containing compounds. Prog Food Nutr Sci 10:133\u2013178","journal-title":"Prog Food Nutr Sci"},{"key":"9900_CR38","doi-asserted-by":"crossref","first-page":"756","DOI":"10.1016\/S0168-8278(03)00376-3","volume":"39","author":"J George","year":"2003","unstructured":"George J, Pera N, Phung N, Leclercq I, Yun Hou J, Farrell G (2003) Lipid peroxidation, stellate cell activation and hepatic fibrogenesis in a rat model of chronic steatohepatitis. Hepatology 39:756\u2013764","journal-title":"Hepatology"},{"key":"9900_CR39","doi-asserted-by":"crossref","unstructured":"Weissbach H, Etienne F, Hoshi T, Heinemann SH, Lowther WT, Matthews B, St John G, Nathan C, Brot N (2002) Arch Biochem Biophys 397:172\u2013178","DOI":"10.1006\/abbi.2001.2664"},{"key":"9900_CR40","doi-asserted-by":"crossref","first-page":"1159","DOI":"10.1073\/pnas.0308215100","volume":"101","author":"O Yermolaieva","year":"2004","unstructured":"Yermolaieva O, Xu R, Schinstock C, Brot N, Weissbach H, Heinemann SH, Hoshi T (2004) Methionine sulfoxide reductase A protects neuronal cells against brief hypoxia\/reoxygenation. Proc Natl Acad Sci USA 101:1159\u20131164","journal-title":"Proc Natl Acad Sci USA"},{"key":"9900_CR41","doi-asserted-by":"crossref","first-page":"917","DOI":"10.1016\/j.jhep.2004.02.011","volume":"40","author":"H Matsui","year":"2004","unstructured":"Matsui H, Ikeda K, Nakajima Y, Horikawa S, Imanishi Y, Kawada N (2004) Sulfur-containing amino acids attenuate the development of liver fibrosis in rats through down-regulation of stellate cell activation. J Hepatol 40:917\u2013925","journal-title":"J Hepatol"},{"key":"9900_CR42","doi-asserted-by":"crossref","first-page":"361","DOI":"10.1002\/jbt.20042","volume":"18","author":"HS Oz","year":"2004","unstructured":"Oz HS, McClain CJ, Nagasaw HT, Ray MB, de Villiers WSJ, Chen TS (2004) Diverse antioxidants protect against acetaminophen hepatotoxicity. J Biochem Mol Toxicol 18:361\u2013368","journal-title":"J Biochem Mol Toxicol"},{"issue":"5","key":"9900_CR43","doi-asserted-by":"crossref","first-page":"297","DOI":"10.1016\/j.jnutbio.2004.09.007","volume":"16","author":"HS Oz","year":"2005","unstructured":"Oz HS, Chen T, McClain C, de Villiers W (2005) Antioxidants a novel therapy in a murine model of colitis. J Nutr Biochem 16(5):297\u2013304","journal-title":"J Nutr Biochem"},{"key":"9900_CR44","doi-asserted-by":"crossref","first-page":"122","DOI":"10.1016\/j.trsl.2006.12.010","volume":"150","author":"HS Oz","year":"2005","unstructured":"Oz HS, Chen T, Nagasawa H (2007) Comparative efficacies of two cysteine prodrugs and a glutathione delivery agent in a colitis model. Transl Res 150:122\u2013129","journal-title":"Transl Res"},{"key":"9900_CR45","doi-asserted-by":"crossref","first-page":"39","DOI":"10.1002\/jbt.20109","volume":"20","author":"HS Oz","year":"2006","unstructured":"Oz HS, Hee-Jeong IM, Chen TS, de Villiers WJS, McClain CJ (2006) Glutathione enhancing agents protect against steatohepatitis in a model. J Biochem Mol Toxicol 20:39\u201347","journal-title":"J Biochem Mol Toxicol"},{"key":"9900_CR46","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1016\/S1357-2725(99)00139-9","volume":"32","author":"SC Lu","year":"2000","unstructured":"Lu SC (2000) S-Adenosylmethionine. Int J Biochem Cell Biol 32:391\u2013395","journal-title":"Int J Biochem Cell Biol"},{"key":"9900_CR47","doi-asserted-by":"crossref","first-page":"67","DOI":"10.1016\/j.alcohol.2004.07.007","volume":"34","author":"CJ McClain","year":"2004","unstructured":"McClain CJ, Prakash S Mokshagundam L, Barve S, Song Z, Hill D, Chen T (2004) Deaciuc I mechanisms of non-alcoholic steatohepatitis. Alcohol 34:67\u201379","journal-title":"Alcohol"},{"issue":"2","key":"9900_CR48","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1002\/hep.21530","volume":"45","author":"S Donthamsetty","year":"2007","unstructured":"Donthamsetty S, Bhave VS, Mitra MS, Latendresse JR, Mehendale HM (2007) Nonalcoholic fatty liver sensitizes rats to carbon tetrachloride hepatotoxicity. Hepatology 45(2):391\u2013411","journal-title":"Hepatology"},{"key":"9900_CR49","first-page":"273","volume":"9","author":"L Miele","year":"2005","unstructured":"Miele L, Forgione A, Hernandez AP, Gabrieli ML, Vero V, Di Rocco P, Greco AV, Gasbarrini G, Gasbarrini A, Grieco A (2005) The natural history and risk factors for progression of non-alcoholic fatty liver disease and steatohepatitis. Eur Rev Med Pharmacol Sci 9:273\u2013278","journal-title":"Eur Rev Med Pharmacol Sci"}],"container-title":["Digestive Diseases and Sciences"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-9900-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s10620-007-9900-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s10620-007-9900-7","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,5,30]],"date-time":"2019-05-30T15:43:45Z","timestamp":1559231025000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s10620-007-9900-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,8,21]]},"references-count":49,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,3]]}},"alternative-id":["9900"],"URL":"https:\/\/doi.org\/10.1007\/s10620-007-9900-7","relation":{},"ISSN":["0163-2116","1573-2568"],"issn-type":[{"value":"0163-2116","type":"print"},{"value":"1573-2568","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,8,21]]}}}